These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7327499

  • 1. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M.
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):543-55. PubMed ID: 7327499
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M.
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
    [No Abstract] [Full Text] [Related]

  • 3. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
    Katano M, Torisu M.
    Surgery; 1983 Mar; 93(3):365-73. PubMed ID: 6600854
    [Abstract] [Full Text] [Related]

  • 4. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.
    Torisu M, Katano M, Kimura Y, Itoh H, Takesue M.
    Surgery; 1983 Mar; 93(3):357-64. PubMed ID: 6187080
    [No Abstract] [Full Text] [Related]

  • 5. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M, Yamamoto H, Mizoguchi T, Hidaka K, Hisatsugu T, Torisu M.
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y, Torisu M.
    Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T.
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [Abstract] [Full Text] [Related]

  • 10. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. II. Experimental study using human malignant ascites].
    Umemoto T, Saji S, Oonishi A, Kunii Y, Goshima H, Tachibana S, Takao H, Tanemura H, Sakata K.
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul 20; 23(7):1512-7. PubMed ID: 3183459
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
    Mori H, Itoh N, Tamaya T.
    Immunopharmacol Immunotoxicol; 1989 Jul 20; 11(1):33-53. PubMed ID: 2503555
    [Abstract] [Full Text] [Related]

  • 12. [Immunohistological studies of the skin at the injection site of cases receiving the streptococcal agent OK-432].
    Hanaue H, Kurosawa T, Miyakawa S, Horie F, Nemoto A, Yamoto H, Nishimura S, Tsuchiya H, Miura S, Asagoe T.
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec 20; 20(10):2271-8. PubMed ID: 3879494
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of T-cell lymphoma with immunotherapy of OK-432--a case report (author's transl)].
    Nakayama S, Tsuji K, Kitajima K, Ueno K, Hoshino T.
    Rinsho Ketsueki; 1980 Jan 20; 21(1):66-72. PubMed ID: 6966340
    [No Abstract] [Full Text] [Related]

  • 14. Malignant ascites treated with streptococcal extract.
    Lancet; 1983 Jun 04; 1(8336):1258. PubMed ID: 6134047
    [No Abstract] [Full Text] [Related]

  • 15. Effects of intraperitoneal administration of OK-432 for patients with advanced cancer.
    Toge T, Yamada H, Aratani K, Kameda A, Kuroi K, Hisamatsu K, Hattori T.
    Jpn J Surg; 1985 Jul 04; 15(4):260-5. PubMed ID: 2932585
    [Abstract] [Full Text] [Related]

  • 16. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y, Ohgaki K, Henmi K, Kan N, Inamoto T, Tsuchitani T, Kodama H, Tobe T.
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr 20; 17(3):728-34. PubMed ID: 6752308
    [No Abstract] [Full Text] [Related]

  • 17. Intratumoral administration of streptococcal preparation (OK-432) to advanced pancreatic cancer.
    Kodama M, Tanaka T.
    Hiroshima J Med Sci; 1983 Jun 20; 32(2):167-71. PubMed ID: 6618899
    [No Abstract] [Full Text] [Related]

  • 18. [Immunotherapy of non-resectable or recurrent cancer with a streptococcal preparation, OK-432--changes in immunologic parameters and evaluation of the periods of survival following intradermal and intramuscular injections].
    Hanaue H, Nomoto S, Seto A, Kimura T, Kutsuna T, Takeuchi T, Yoshizaki S.
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec 20; 17(8):1975-85. PubMed ID: 7169568
    [No Abstract] [Full Text] [Related]

  • 19. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y, Maeda M, Koyama W, Totsuka S, Sakamoto S, Kanayama M.
    Gan To Kagaku Ryoho; 1988 Jun 20; 15(6):1978-80. PubMed ID: 3382244
    [Abstract] [Full Text] [Related]

  • 20. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G.
    Nihon Geka Gakkai Zasshi; 1990 Jan 20; 91(1):68-76. PubMed ID: 2314383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.